Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
INT-1B3
i
Other names:
INT-1B3, INT 1B3
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
InteRNA Tech
Drug class:
CD73 inhibitor, CD39 inhibitor
Related drugs:
‹
MEDI9447 (6)
TJD5 (3)
ABSK051 (0)
BMS-986179 (0)
BP1200 (0)
HB0045 (0)
HLX23 (0)
INCA00186 (0)
IPH5301 (0)
NZV930 (0)
ORIC-533 (0)
PM1015 (0)
S95024 (0)
AGEN1423 (0)
AK119 (0)
CPI-006 (0)
AB680 (0)
AB598 (0)
IPH5201 (0)
JS019 (0)
TTX-030 (0)
SRF617 (0)
MEDI9447 (6)
TJD5 (3)
ABSK051 (0)
BMS-986179 (0)
BP1200 (0)
HB0045 (0)
HLX23 (0)
INCA00186 (0)
IPH5301 (0)
NZV930 (0)
ORIC-533 (0)
PM1015 (0)
S95024 (0)
AGEN1423 (0)
AK119 (0)
CPI-006 (0)
AB680 (0)
AB598 (0)
IPH5201 (0)
JS019 (0)
TTX-030 (0)
SRF617 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
HOXA9 overexpression + MEIS1 overexpression
Acute Myelogenous Leukemia
HOXA9 overexpression + MEIS1 overexpression
Acute Myelogenous Leukemia
INT-1B3
Sensitive: D – Preclinical
INT-1B3
Sensitive
:
D
INT-1B3
Sensitive: D – Preclinical
INT-1B3
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login